(Q90400739)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31572298%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

review article

1 reference

title

Management Strategies for POSEIDON Groups 3 and 4 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31572298%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31572298%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

author name string

Thor Haahr

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31572298%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Carlos Dosouto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31572298%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Carlo Alviggi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31572298%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Peter Humaidan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31572298%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

publication date

11 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31572298%20AND%20SRC:MED&resulttype=core&format=json

Frontiers in Endocrinology

13 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31572298%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31572298%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

page(s)

614

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31572298%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

13 April 2020

copyright license

start time

11 September 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization.

1 reference

12 December 2020

Direct gonadotrophic effect of growth hormone on oestradiol production by human granulosa cells in vitro

1 reference

12 December 2020

Insulin-like growth factor-I regulates aromatase activity in human granulosa and granulosa luteal cells

1 reference

12 December 2020

Glycoprotein Hormones: Structure and Function

1 reference

12 December 2020

A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse)

1 reference

12 December 2020

Evidence from a salvaged treatment cycle supports an aetiology for the empty follicle syndrome that is related to terminal follicular developmental events.

1 reference

12 December 2020

Androgens stimulate early stages of follicular growth in the primate ovary

1 reference

12 December 2020

Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations.

1 reference

12 December 2020

A randomized three-way cross-over study in healthy pituitary-suppressed women to compare the bioavailability of human chorionic gonadotrophin (Pregnyl) after intramuscular and subcutaneous administration.

1 reference

12 December 2020

Deficits in female reproductive function in GH-R-KO mice; role of IGF-I.

1 reference

12 December 2020

Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary.

1 reference

12 December 2020

Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development.

1 reference

12 December 2020

Empty follicle syndrome: evidence for recurrence

1 reference

12 December 2020

Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization

1 reference

12 December 2020

Growth hormone is required for ovarian follicular growth

1 reference

12 December 2020

EGF-like growth factors as mediators of LH action in the ovulatory follicle.

1 reference

12 December 2020

A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization

1 reference

12 December 2020

Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial

1 reference

12 December 2020

GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study

1 reference

12 December 2020

Exploiting LH in ovarian stimulation

1 reference

12 December 2020

Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial.

1 reference

12 December 2020

Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial

1 reference

12 December 2020

A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial.

1 reference

12 December 2020

Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles.

1 reference

12 December 2020

Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.

1 reference

12 December 2020

Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization

1 reference

12 December 2020

Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists--a randomized study.

1 reference

12 December 2020

What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders?

1 reference

12 December 2020

Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis.

1 reference

12 December 2020

Minimal stimulation using gonadotropin-releasing hormone (GnRH) antagonist and recombinant human follicle-stimulating hormone versus GnRH antagonist multiple-dose protocol in low responders undergoing in vitro fertilization/intracytoplasmic sperm in

1 reference

12 December 2020

Growth hormone for in vitro fertilization

1 reference

12 December 2020

Interventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF)

1 reference

12 December 2020

Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis

1 reference

12 December 2020

Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouse

1 reference

12 December 2020

Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles

1 reference

12 December 2020

Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles.

1 reference

12 December 2020

Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF

1 reference

12 December 2020

Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: a randomized, controlled trial.

1 reference

12 December 2020

Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF.

1 reference

12 December 2020

A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel?

1 reference

12 December 2020

A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer.

1 reference

12 December 2020

The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis.

1 reference

12 December 2020

Empty follicle syndrome: successful treatment in a recurrent case and review of the literature

1 reference

12 December 2020

Moderate ovarian stimulation does not increase the incidence of human embryo chromosomal abnormalities in in vitro fertilization cycles

1 reference

12 December 2020

Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria

1 reference

12 December 2020

(Meta)analyze this: Systematic reviews might lose credibility.

1 reference

12 December 2020

Effects of transdermal testosterone in poor responders undergoing IVF: systematic review and meta-analysis

1 reference

12 December 2020

Flexible ovarian stimulation in a poor responder: a case report and literature review.

1 reference

12 December 2020

Cycle scheduling for in vitro fertilization with oral contraceptive pills versus oral estradiol valerate: a randomized, controlled trial

1 reference

12 December 2020

Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles.

1 reference

12 December 2020

Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial

1 reference

12 December 2020

Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis.

1 reference

12 December 2020

Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation?

1 reference

12 December 2020

Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection.

1 reference

12 December 2020

Co-administration of GnRH-agonist and hCG for final oocyte maturation (double trigger) in patients with low number of oocytes retrieved per number of preovulatory follicles--a preliminary report

1 reference

12 December 2020

Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low proportion of mature oocytes.

1 reference

12 December 2020

Twenty years' experience with the Swiss data registry for assisted reproductive medicine: outcomes, key trends and recommendations for improved practice

1 reference

12 December 2020

Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles

1 reference

12 December 2020

Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction

1 reference

12 December 2020

Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?

1 reference

12 December 2020

A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept.

1 reference

12 December 2020

Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation.

1 reference

12 December 2020

Dehydroepiandrosterone treatment in women with poor ovarian response undergoing IVF or ICSI: a systematic review and meta-analysis

1 reference

12 December 2020

Testosterone for Poor Ovarian Responders: Lessons From Ovarian Physiology.

1 reference

12 December 2020

Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders

1 reference

12 December 2020

The novel POSEIDON stratification of 'Low prognosis patients in Assisted Reproductive Technology' and its proposed marker of successful outcome.

1 reference

12 December 2020

The cumulative dose of gonadotropins used for controlled ovarian stimulation does not influence the odds of embryonic aneuploidy in patients with normal ovarian response

1 reference

12 December 2020

The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: A systematic review and meta-analysis

1 reference

12 December 2020

Use of various gonadotropin and biosimilar formulations for in vitro fertilization cycles: results of a worldwide Web-based survey.

1 reference

12 December 2020

Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the "Personalized" Medicine Era: A Meta-analysis.

1 reference

12 December 2020

GnRH Agonist Trigger and LH Activity Luteal Phase Support versus hCG Trigger and Conventional Luteal Phase Support in Fresh Embryo Transfer IVF/ICSI Cycles-A Systematic PRISMA Review and Meta-analysis

1 reference

12 December 2020

Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing ovarian stimulation for fertility preservation.

1 reference

12 December 2020

Retrospective analysis of treatments with recombinant FSH and recombinant LH versus human menopausal gonadotropin in women with reduced ovarian reserve.

1 reference

12 December 2020

High gonadotropin dosage does not affect euploidy and pregnancy rates in IVF PGS cycles with single embryo transfer.

1 reference

12 December 2020

Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.

1 reference

12 December 2020

Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 1: The predicted poor responder.

1 reference

12 December 2020

Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial.

1 reference

12 December 2020

The end for individualized dosing in IVF ovarian stimulation? Reply to letters-to-the-editor regarding the OPTIMIST papers

1 reference

12 December 2020

OPTIMIST trial: optimistic evidence?

1 reference

12 December 2020

Poor definition of poor-ovarian response results in misleading clinical recommendations

1 reference

12 December 2020

Individualized FSH dosing improves safety and reduces iatrogenic poor response while maintaining live-birth rates

1 reference

12 December 2020

Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review

1 reference

12 December 2020

Two Hormones for One Receptor: Evolution, Biochemistry, Actions, and Pathophysiology of LH and hCG

1 reference

12 December 2020

Luteal phase anovulatory follicles result in the production of competent oocytes: intra-patient paired case-control study comparing follicular versus luteal phase stimulations in the same ovarian cycle

1 reference

12 December 2020

Comparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a guideline

1 reference

12 December 2020

Estimation of age-dependent decrease in blastocyst euploidy by next generation sequencing: development of a novel prediction model

1 reference

12 December 2020

Double Stimulation in the Same Ovarian Cycle (DuoStim) to Maximize the Number of Oocytes Retrieved From Poor Prognosis Patients: A Multicenter Experience and SWOT Analysis.

1 reference

12 December 2020

Novel approaches for diagnosis and management of low prognosis patients in assisted reproductive technology: the POSEIDON concept

1 reference

12 December 2020

Dosage of exogenous gonadotropins is not associated with blastocyst aneuploidy or live-birth rates in PGS cycles in Chinese women

1 reference

12 December 2020

Understanding Ovarian Hypo-Response to Exogenous Gonadotropin in Ovarian Stimulation and Its New Proposed Marker-The Follicle-To-Oocyte (FOI) Index

1 reference

12 December 2020

GnRH agonist long protocol versus GnRH antagonist protocol for various aged patients with diminished ovarian reserve: A retrospective study

1 reference

12 December 2020

Cumulative live birth rate prognosis based on the number of aspirated oocytes in previous ART cycles

1 reference

12 December 2020

Advances in ovulation trigger strategies

1 reference

12 December 2020

The role of recombinant LH in women with hypo-response to controlled ovarian stimulation: a systematic review and meta-analysis

1 reference

12 December 2020

Dual stimulation using corifollitropin alfa in 54 Bologna criteria poor ovarian responders - a case series

1 reference

12 December 2020

Does double trigger (GnRH-agonist + hCG) improve outcome in poor responders undergoing IVF-ET cycle? A pilot study

1 reference

12 December 2020

A Novel Predictive Model to Estimate the Number of Mature Oocytes Required for Obtaining at Least One Euploid Blastocyst for Transfer in Couples Undergoing Fertilization/Intracytoplasmic Sperm Injection: The ART Calculator

1 reference

12 December 2020

Human growth hormone for poor responders: a randomized placebo-controlled trial provides no evidence for improved live birth rate

1 reference

12 December 2020

Identifiers

DOI

10.3389/FENDO.2019.00614

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31572298%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31572298%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

1 reference